These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35076342)

  • 1. Emerging therapeutic targets for cardiac hypertrophy.
    Winkle AJ; Nassal DM; Shaheen R; Thomas E; Mohta S; Gratz D; Weinberg SH; Hund TJ
    Expert Opin Ther Targets; 2022 Jan; 26(1):29-40. PubMed ID: 35076342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?
    Balakumar P; Jagadeesh G
    Pharmacol Res; 2010 Nov; 62(5):365-83. PubMed ID: 20643208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure.
    Oka T; Komuro I
    Circ J; 2008; 72 Suppl A():A13-6. PubMed ID: 18772527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
    Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
    Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
    Wang Y; Keskanokwong T; Cheng J
    J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF6 Regulates Cardiac Hypertrophy by Transcriptional Induction of the mTORC1 Activator, Rheb.
    Blackwood EA; Hofmann C; Santo Domingo M; Bilal AS; Sarakki A; Stauffer W; Arrieta A; Thuerauf DJ; Kolkhorst FW; Müller OJ; Jakobi T; Dieterich C; Katus HA; Doroudgar S; Glembotski CC
    Circ Res; 2019 Jan; 124(1):79-93. PubMed ID: 30582446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic screen quantifying differential regulation of cardiac myocyte hypertrophy identifies CITED4 regulation of myocyte elongation.
    Ryall KA; Bezzerides VJ; Rosenzweig A; Saucerman JJ
    J Mol Cell Cardiol; 2014 Jul; 72():74-84. PubMed ID: 24613264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network reconstruction and systems analysis of cardiac myocyte hypertrophy signaling.
    Ryall KA; Holland DO; Delaney KA; Kraeutler MJ; Parker AJ; Saucerman JJ
    J Biol Chem; 2012 Dec; 287(50):42259-68. PubMed ID: 23091058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of autophagy in pathological cardiac hypertrophy.
    Li Z; Wang J; Yang X
    Int J Biol Sci; 2015; 11(6):672-8. PubMed ID: 25999790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy.
    Bass GT; Ryall KA; Katikapalli A; Taylor BE; Dang ST; Acton ST; Saucerman JJ
    J Mol Cell Cardiol; 2012 May; 52(5):923-30. PubMed ID: 22142594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage microRNA-155 promotes cardiac hypertrophy and failure.
    Heymans S; Corsten MF; Verhesen W; Carai P; van Leeuwen RE; Custers K; Peters T; Hazebroek M; Stöger L; Wijnands E; Janssen BJ; Creemers EE; Pinto YM; Grimm D; Schürmann N; Vigorito E; Thum T; Stassen F; Yin X; Mayr M; de Windt LJ; Lutgens E; Wouters K; de Winther MP; Zacchigna S; Giacca M; van Bilsen M; Papageorgiou AP; Schroen B
    Circulation; 2013 Sep; 128(13):1420-32. PubMed ID: 23956210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy.
    Lieu M; Koch WJ
    Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf-mediated cardiac hypertrophy in adult Drosophila.
    Yu L; Daniels J; Glaser AE; Wolf MJ
    Dis Model Mech; 2013 Jul; 6(4):964-76. PubMed ID: 23580199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA
    Yu J; Yang Y; Xu Z; Lan C; Chen C; Li C; Chen Z; Yu C; Xia X; Liao Q; Jose PA; Zeng C; Wu G
    Circ Heart Fail; 2020 Jan; 13(1):e006525. PubMed ID: 31957467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
    Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.